{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:39:40Z","timestamp":1770979180563,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ygyno.2021.09.015","type":"journal-article","created":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T04:54:27Z","timestamp":1633150467000},"page":"453-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["MicroRNA profiling in a case-control study of African American women with uterine serous carcinoma"],"prefix":"10.1016","volume":"163","author":[{"given":"Larissa","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Howitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Stawiski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipanjan","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Matulonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis A.","family":"Konstantinopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2021.09.015_bb0005","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.ygyno.2021.09.015_bb0020","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/cncr.22232","article-title":"Racial disparity in survival among patients with advanced\/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"107","author":"Maxwell","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2021.09.015_bb0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/cncr.24769","article-title":"Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study","volume":"116","author":"Farley","year":"2010","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2021.09.015_bb0030","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2629::AID-CNCR30>3.0.CO;2-2","article-title":"The National Cancer Data Base report on endometrial carcinoma in African-American women","volume":"83","author":"Hicks","year":"1998","journal-title":"Cancer"},{"issue":"22","key":"10.1016\/j.ygyno.2021.09.015_bb0035","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1200\/JCO.2003.01.218","article-title":"Differences in treatment and outcome between African-American and white women with endometrial cancer","volume":"21","author":"Randall","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.015_bb0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/cncr.11484","article-title":"Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus","volume":"98","author":"Sherman","year":"2003","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2021.09.015_bb0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/GRF.0b013e318218c755","article-title":"Uterine papillary serous carcinoma","volume":"54","author":"Moore","year":"2011","journal-title":"Clin. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.015_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/IGC.0000000000000844","article-title":"Survival differences among uterine papillary serous, clear cell and grade 3 endometrioid adenocarcinoma endometrial cancers: a national cancer database analysis","volume":"27","author":"McGunigal","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2021.09.015_bb0055","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ygyno.2016.03.002","article-title":"Racial disparity in survival of patients with uterine serous carcinoma: changes in clinical characteristics, patterns of care and outcomes over time from 1988 to 2011","volume":"143","author":"Mahdi","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.09.015_bb0060","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA Pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"W1","key":"10.1016\/j.ygyno.2021.09.015_bb0065","doi-asserted-by":"crossref","first-page":"W110","DOI":"10.1093\/nar\/gkw345","article-title":"miEAA: microRNA enrichment analysis and annotation","volume":"44","author":"Backes","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ygyno.2021.09.015_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa707","article-title":"MNDR v3.0: mammal ncRNA-disease repository with increased coverage and annotation","volume":"49","author":"Ning","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.ygyno.2021.09.015_bb0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/j.ygyno.2021.09.015_bb0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2021.09.015_bb0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu. Rev. Biochem."},{"issue":"6","key":"10.1016\/j.ygyno.2021.09.015_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.02.051","article-title":"Comprehensive miRNA profiling of surgically staged endometrial cancer","volume":"202","author":"Cohn","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2021.09.015_bb0095","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2147\/OTT.S272222","article-title":"Construction of miRNA-mRNA regulatory network and prognostic signature in endometrial cancer","volume":"14","author":"Sun","year":"2021","journal-title":"Onco Targets Ther"},{"issue":"7","key":"10.1016\/j.ygyno.2021.09.015_bb0100","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/ijc.27840","article-title":"Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients","volume":"132","author":"Torres","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2021.09.015_bb0105","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1111\/jcmm.15111","article-title":"Novel miRNA markers for the diagnosis and prognosis of endometrial cancer","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"7447","key":"10.1016\/j.ygyno.2021.09.015_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ygyno.2021.09.015_bb0115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ygyno.2010.05.010","article-title":"MicroRNA signatures differentiate uterine cancer tumor subtypes","volume":"118","author":"Ratner","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.09.015_bb0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.humpath.2018.02.019","article-title":"MicroRNA signatures discriminate between uterine and ovarian serous carcinomas","volume":"76","author":"Hui","year":"2018","journal-title":"Hum. Pathol."},{"issue":"42","key":"10.1016\/j.ygyno.2021.09.015_bb0125","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1038\/onc.2011.539","article-title":"A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer","volume":"31","author":"Ratner","year":"2012","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.ygyno.2021.09.015_bb0130","doi-asserted-by":"crossref","first-page":"10307","DOI":"10.1158\/0008-5472.CAN-08-1954","article-title":"MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2021.09.015_bb0135","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejca.2009.10.027","article-title":"MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types","volume":"46","author":"Hummel","year":"2010","journal-title":"Eur. J. Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2021.09.015_bb0140","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1158\/1535-7163.MCT-08-0021","article-title":"Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin","volume":"7","author":"Kovalchuk","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"44","key":"10.1016\/j.ygyno.2021.09.015_bb0145","doi-asserted-by":"crossref","first-page":"29897","DOI":"10.1074\/jbc.M804612200","article-title":"MicroRNA-221\/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1","volume":"283","author":"Miller","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ygyno.2021.09.015_bb0150","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/ijgc-2021-002494","article-title":"Detection of microRNA in urine to identify patients with endometrial cancer: a feasibility study","volume":"31","author":"Donkers","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.015_bb0155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3892\/ol.2013.1338","article-title":"Identification of four serum microRNAs from a genome-wide serum microRNA expression profile as potential non-invasive biomarkers for endometrioid endometrial cancer","volume":"6","author":"Jia","year":"2013","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.ygyno.2021.09.015_bb0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ajcp\/aqx004","article-title":"Early miR-223 upregulation in gastroesophageal carcinogenesis","volume":"147","author":"Fassan","year":"2017","journal-title":"Am. J. Clin. Pathol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821013846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821013846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:57:40Z","timestamp":1758772660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821013846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0090825821013846"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.09.015","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA profiling in a case-control study of African American women with uterine serous carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}